Everads Therapy Enters Into Option Agreement With Global Pharma Company

​

Everads Therapy,  developing the next generation of retinal treatment delivery technologies, today announced that it has signed an option agreement with a large global pharmaceutical company. This is Everads' first commercial agreement, and its signing supports the potential of its technology to overcome certain risks and side effects associated with current retinal disease treatment options. 

SoftWheel is Delighted to Announce Investment by Mitsubishi Corporation

​

SoftWheel develops cutting edge systems for the automotive industry. Its innovative technology enables significant reduction in space, weight, and energy consumption of vehicle platforms for EV, hybrid, and autonomous vehicles.

Moebius and Sun Pharma sign osteoarthritis drug licensing deal

​

Israeli drug development company Moebius Medical has entered into an exclusive worldwide licensing deal with India's Sun Pharmaceutical Industries to develop MM-II, a novel pharmaceutical candidate for the treatment of osteoarthritis pain.

EON Surgical acquired by Teleflex 

​

EON Medical was acquired by Teleflex in 2013. The company’s 2.9 mm Percuvance Percutaneous Surgical System was engineered to reduce trauma while delivering the performance previously offered only by 5 mm laparoscopic devices.

2017: a pivotal year for SteadyMed

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.

Simbionix

Simbionix acquired by

3D SYSTEMS 

Simbionix, a provider of innovative training and education solutions for the healthcare industry, was acquired by 3D SYSTEMS in 2014.